Markets
9 views
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
CNBC Verified Source
Syndicated via official news feed
Explore all Markets stories
Syndicated feed content with full publisher credit.
Markets Desk
More in Markets
Continue reading verified coverage and related developments on this desk.
More from Markets
Latest developments and reports from the desk
MARKETS
Coffee chain Blank Street raises funds from General Atlantic to fuel expansion
Latest fundraising values the six-year-old company at about $650mn as it aims to be ‘daily luxury brand’
MARKETS
‘I don’t have any close friends in business’: Euronext CEO on a decade shaping Europe’s markets
Stéphane Boujnah has obsessively chased acquisitions to compete with larger rivals
MARKETS
Who owns government bonds?
As governments borrow more, the buyers of their debt are changing